Article
Evodiamine activates cellular apoptosis through suppressing PI3K/AKT and activating MAPK…
OncoTargets and Therapy · 2018 · Wang R, Deng D, Shao N, Xu Y, Xue L, Peng Y, Liu Y, Zhi F
Key facts
| Title | Evodiamine activates cellular apoptosis through suppressing PI3K/AKT and activating MAPK in glioma |
|---|---|
| First author | Wang R, Deng D, Shao N, Xu Y, Xue L, Peng Y, Liu Y, Zhi F |
| Journal | OncoTargets and Therapy |
| Published | Mar 2, 2018 |
| DOI | 10.2147/OTT.S155275 |
| Devices mentioned | K832688, K841744, K843086, K850090, K850092, K850891, K851606, K870478, K870482, K870492, K870496 |
| Product codes mentioned | KIP, KIT |
At a glance
- 10–99 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1